DKSH has acquired two ear care brands, Audisol and Audiplugs, from Noru Pharma to enhance its Healthcare Own Brands business in Australia, New Zealand, and selected Asian markets.
Information on the Target
DKSH has reached an agreement to acquire two ear care brands, Audisol and Audiplugs, from Noru Pharma specifically for Australia, New Zealand, and certain markets in Asia. Audisol offers a diverse range of products addressing everyday ear treatment needs, while Audiplugs provides high-quality earplugs designed for a variety of consumers. These brands are already established in markets including Australia, New Zealand, and Singapore, with plans for DKSH to gradually introduce them to additional markets as opportunities arise.
Industry Overview
The ear care industry is experiencing significant growth in Australia and New Zealand, fueled by increasing consumer awareness around healthcare and the importance of ear health. Over-the-counter (OTC) ear care products have seen a notable rise in demand as consumers seek solutions for ear hygiene, protection, and treatment. Factors such as a growing aging population and lifestyle changes contribute to the increasing prevalence of ear-related issues, prompting a shift towards preventive care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
In recent years, the healthcare sector in Australia and New Zealand has been characterized by robust growth and innovation. Companies are investing in new product development and marketing strategies to ca
Similar Deals
Cold Chain Technologies → Global Cold Chain Solutions
2023
Vimian Group AB → iM3 Dental Limited and iM3 Pty Ltd
2023
Bridgewest Group → Perth sterile injectable manufacturing facility
2023
Next Capital → InterHealthcare
2020
T-Pro → Sound Business Systems Limited (SBS)
DKSH
invested in
Audisol and Audiplugs
in 2022
in a Buy & Build / Roll-Up deal
Disclosed details
Revenue: $2M